• Mutual Funds
  • Nippon India Mutual Fund
  • Nippon India Pharma Fund (G)
Nippon Mutual Fund

Nippon India Pharma Fund (G)

EquitySectoral / Thematic - Pharma And Healthcare

528.5979

NAV (Oct 15)

30.461%
5 Year CAGR
Scripbox Opinion
Neutral
Click here for top ranked funds in sectoral / thematic - pharma and healthcare mutual funds.

Sectoral / Thematic - Pharma And Healthcare funds provides inflation beating growth over the long term and is suitable for investment objectives with duration of 10-15 years or longer (minimum 5 years).

The pharma benchmark index itself has been a material underperformer over an extended time frame.

Contrary to common perception, this category is also characterised by higher volatility.Investing in these funds will require investors to have a unique insight into the specific areas of investment that these funds focus on.In addition the investor will need to have the ability,inclination and expertise to monitor the prospects closely.Investors are therefore better off investing in diversified funds rather than this category.

Our analysis of this fundLearn how we rate funds ->

Downside Protection Measure

Neutral

The performance of the fund on a Downside Protection Measure metric has been Neutral

Fund Size

Category Leader

The fund has been a Category Leader on the Fund Size metric

Scripbox Recommended Equity Funds
Want the equity funds that are right for your long term equity investment needs?Learn more

Investment Calculator

Investment Duration5 years

0

Total Investment

0

Wealth Gained

0

Total Corpus Created (₹)

With CAGR of 11.25 % in 5 years

Historical NAV

528.5979

NAV (Oct 15)

Fund Returns

Last 1Y
50.4%
Last 3Y
19.2%
Last 5Y
30.5%
Last 10Y
16.3%
Since Inception
21.5%
6 Month CAGR
23.9%

Scheme Information

Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Expense Ratio
1.82
Launched (0y ago)
1.82
AUM in Crores
8768.7
ISIN
INF204K01968
Lock-in
-
Benchmark
BSE Healthcare Total Return Index
SIP Minimum
1000
Lumpsum Min.
5000
Standard Deviation (3yr)
-
Standard Deviation
15.1
Beta
0.9
Sharpe Ratio
0.7
YTM
-
Fund Managers

Sailesh Raj Bhan

Fund Manager

Important Links

Scheme Information Document

Statement of Additional Information

Portfolio Disclosure

Returns Calculator Comparison

of

for

with step up of

AssetReturnsTotal CorpusGainsCAGR
Nippon India Pharma Fund (G)70%16,32,217 8,99,60530.5%
EPF70% 9,00,761 1,68,1498.50%
Property70% 8,67,662 1,35,0507.00%
PPF70% 8,69,819 1,37,2077.10%
Bank FD70% 8,46,471 1,13,8596.00%
Gold70% 8,46,471 1,13,8596.00%
Savings Bank70% 8,25,950 93,3385.00%

Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.

Asset allocation and Holdings

Last updated on 2024-05-17

Top Stock Holdings

Sun Pharmaceutical Industries Ltd.

13.9%
13.85%

Divi's Laboratories Ltd.

8.2%
8.17%

Lupin Ltd.

7.5%
7.52%

Cipla Ltd.

5.9%
5.88%

Dr. Reddy's Laboratories Ltd.

5.8%
5.81%
See all holdings

Allocation by Sector

Healthcare

98.4%
98.44%
See all sectors

Comparison with Equity Funds

Fund NameFund Size
mirae-asset-global
Mirae Asset ELSS Tax Saver Fund (G)

₹ 26,417 cr

₹ 24,508 cr

₹ 66,206 cr

₹ 51,197 cr

₹ 17,770 cr

amc-img

About the AMC

Nippon India Mutual Fund

Reliance Nippon India Mutual Fund was established in 1996. It is a joint venture between India's Reliance Mutual Fund and Japan's Nippon Life Insurance Company. It is india's top asset management company with a total AUM of Rs 1.8 Lac Crore with about 91.9 lac active folios. It is the first compnay to be listed and traded on both the NSE and Bombay Stock Exchange (BSE).amc-img
Fund NameScripbox Opinion
Till Date CAGR

6%

6.9%

7.2%

8.9%

15.7%

20.9%

19.5%

13.6%

15.1%

8.3%

Nippon India Pharma Fund (G) Review

Nippon India Pharma Fund (G) is a Sectoral / Thematic - Pharma And Healthcare Equity fund and has delivered an annualised return of 21.496% over a period of 20 years. The fund is managed by Nippon India Mutual Fund. The fund manager’s name is Sailesh Raj Bhan.

Nav of Nippon India Pharma Fund (G) as of 10/15/2024 is ₹528.60 with the total AUM as of 10/16/2024 is ₹8768.6663. With Scripbox you can compare and check the latest nav for all mutual funds in India. Nippon India Pharma Fund (G) was launched on 2004-06-05. The category risk of the fund is Below Average.

The minimum SIP amount for Nippon India Pharma Fund (G) is ₹1000 and you can increase this in multiples of ₹100. In case you want to invest a lump sum, the minimum amount to be invested is ₹5000. Check your estimated returns on mutual funds by using sip calculator.

Nippon India Pharma Fund (G) is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to BSE Healthcare Total Return Index.

It is rated as a 2 fund in Equity and delivered 50.376% returns in the last 1 year. Scripbox provides a compare mutual funds research tool to view a detailed comparison with Nippon India Pharma Fund (G).

Frequently Asked Questions

What is Nippon India Pharma Fund (G)?

It is a Sectoral / Thematic - Pharma And Healthcare Equity scheme predominantly investing across Equity instruments with an investment objective to generate wealth over the long term.

How to invest in Nippon India Pharma Fund (G)?

You can invest in Nippon India Pharma Fund (G) through AMC, intermediaries, brokers or platforms like Scripbox. To learn step by step process visit how to invest in mutual funds?

What is the minimum sip amount of Nippon India Pharma Fund (G)?

The minimum sip amount for Nippon India Pharma Fund (G) is ₹1000. You can invest in multiples of ₹5000.

Is Nippon India Pharma Fund (G) good to invest in?

As per Scripbox experts, it is a 2 fund. You can invest in it if its investment objective and risk-o-meter matches your investment goals and risk preferences.

What is the expense ratio of the Nippon India Pharma Fund (G)?

The expense ratio of the Nippon India Pharma Fund (G) is 1.82% for regular plan.

What is the NAV of Nippon India Pharma Fund (G)?

Today's Nippon India Pharma Fund (G) NAV is ₹528.60.